Invesco Nasdaq Biotechnology ETF (IBBQ) Institutional Ownership $21.78 +0.17 (+0.79%) As of 01/3/2025 05:22 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$3.95MNumber ofInstitutional Sellers(last 12 months)0 Get IBBQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Invesco Nasdaq Biotechnology ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IBBQ Institutional Buying and Selling by Quarter Invesco Nasdaq Biotechnology ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/23/2024Mirae Asset Global Investments Co. Ltd.259,733$6.16M0.0%+22.7%15.935% 10/11/2024ORG Partners LLC1,067$25K0.0%N/A0.068% 5/14/2024Lake Street Advisors Group LLC12,917$286K0.0%N/A0.879% 4/25/2024Eudaimonia Partners LLC41,612$923K0.2%N/A2.831% 4/25/2024Eudaimonia Advisors LLC70,693$1.57M0.8%N/A4.809% 10/26/2023Mirae Asset Global Investments Co. Ltd.211,596$4.19M0.0%+2.4%25.190% Get the Latest News and Ratings for IBBQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 8/14/2023Partners Capital Investment Group LLP25,717$525K0.0%+100.4%3.062% 8/10/2023Mirae Asset Global Investments Co. Ltd.206,596$4.22M0.0%-0.2%24.595% 5/9/2023Tower Research Capital LLC TRC16,824$348K0.0%+18.4%1.753% 4/21/2023Capital Investment Advisory Services LLC11,001$228K0.0%-5.6%1.146% 2/9/2023Mirae Asset Global Investments Co. Ltd.207,096$4.37M0.0%-30.6%21.800% 2/8/2023Raymond James Financial Services Advisors Inc.29,366$619K0.0%+16.2%3.091% 2/8/2023Banco BTG Pactual S.A.37,266$786K0.4%-2.7%3.923% 11/15/2022Partners Capital Investment Group LLP12,806$242K0.0%N/A1.348% 11/15/2022Lake Street Advisors Group LLC12,806$242K0.0%N/A1.281% 11/15/2022Banco BTG Pactual S.A.38,307$725K0.4%-1.8%3.831% 11/10/2022Tower Research Capital LLC TRC37,649$712K0.0%-12.6%3.765% 10/26/2022Capital Investment Advisory Services LLC11,350$215K0.0%+6.1%1.135% 10/25/2022Raymond James Financial Services Advisors Inc.25,273$478K0.0%N/A2.527% 7/26/2022Mirae Asset Global Investments Co. Ltd.328,196$6.18M0.0%+4.7%29.303% 7/22/2022Capital Investment Advisory Services LLC10,700$201K0.0%+13.8%0.955% 5/3/2022Capital Investment Advisory Services LLC9,400$197K0.0%N/A0.752% 4/22/2022Apexium Financial LP17,299$410K0.2%-4.8%1.384% 2/10/2022Citigroup Inc.100,000$2.37M0.0%-75.0%8.621% 2/8/2022Bank of America Corp DE150,000$3.56M0.0%-62.5%12.931% 1/19/2022Apexium Financial LP18,178$431K0.2%N/A1.567% 11/15/2021Flow Traders U.S. LLC20,000$512K0.0%N/A1.117% 10/18/2021Clarius Group LLC18,752$480K0.0%N/A1.059% 8/16/2021Bank of America Corp DE400,000$10.36M0.0%N/A20.408% 8/16/2021Morgan Stanley400,000$10.36M0.0%N/A20.408% 8/16/2021Credit Suisse AG400,000$10.36M0.0%N/A20.408% 8/12/2021JPMorgan Chase & Co.399,997$10.36M0.0%N/A19.802% (Data available from 1/1/2016 forward) IBBQ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IBBQ shares? During the previous two years, 10 institutional investors and hedge funds held shares of Invesco Nasdaq Biotechnology ETF. The most heavily invested institutionals were Mirae Asset Global Investments Co. Ltd. ($6.16M), Eudaimonia Advisors LLC ($1.57M), Eudaimonia Partners LLC ($923K), Banco BTG Pactual S.A. ($786K), Raymond James Financial Services Advisors Inc. ($619K), Partners Capital Investment Group LLP ($525K), and Tower Research Capital LLC TRC ($348K).Learn more on IBBQ's institutional investors. Which institutional investors have been buying Invesco Nasdaq Biotechnology ETF stock? The following institutional investors have purchased Invesco Nasdaq Biotechnology ETF stock in the last 24 months: Eudaimonia Advisors LLC ($70.69K), Mirae Asset Global Investments Co. Ltd. ($53.14K), Eudaimonia Partners LLC ($41.61K), Lake Street Advisors Group LLC ($12.92K), Partners Capital Investment Group LLP ($12.89K), Raymond James Financial Services Advisors Inc. ($4.09K), and Tower Research Capital LLC TRC ($2.62K). How much institutional buying is happening at Invesco Nasdaq Biotechnology ETF? Institutional investors have bought a total of 199,024 shares in the last 24 months. This purchase volume represents approximately $4.45M in transactions. Which Invesco Nasdaq Biotechnology ETF major shareholders have been selling company stock? The following institutional investors have sold Invesco Nasdaq Biotechnology ETF stock in the last 24 months: Mirae Asset Global Investments Co. Ltd. ($92K), Banco BTG Pactual S.A. ($1.04K), and Capital Investment Advisory Services LLC ($649.00). How much institutional selling is happening at Invesco Nasdaq Biotechnology ETF? Institutional investors have sold a total of 93,690 shares in the last 24 months. This volume of shares sold represents approximately $1.97M in transactions. Related Companies FTXH Major Shareholders BIB Major Shareholders JDOC Major Shareholders BIS Major Shareholders PTH Major Shareholders PSCH Major Shareholders BBH Major Shareholders PPH Major Shareholders IBB Major Shareholders This page (NASDAQ:IBBQ) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.